A Two-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 in Healthy Subjects

Trial Profile

A Two-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2014

At a glance

  • Drugs CAT 2003 (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Adverse reactions
  • Sponsors Catabasis Pharmaceuticals
  • Most Recent Events

    • 02 May 2014 Results presented at the National Lipid Association (NLA) Scientific Sessions 2014, according to to a Catabasis media release.
    • 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
    • 31 Mar 2014 Results will be presented at the American College of Cardiology's 63rd Annual Scientific Session (ACC.14) according to a Catabasis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top